Crimson Wine Group, Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Crimson Wine Group, Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	64.6	63.2	67.8	67.1	64.1	68.9	74.2	72.4	73	65.1
Cost of revenue	31.7	32	37.5	42	44.4	38.9	41.5	38.7	37.9	34.4
Gross profit	33	31.2	30.3	25.1	19.7	30.1	32.8	33.7	35.1	30.7
Selling, general and administrative		26.2	27	29.7	25.6	28.8	30.5	31.7	34.2	32.1
Selling and marketing	15.8	15.4	16.4	18	14.3	15.7	17.4	17.8	18.6	17.3
General and administrative	10.7	10.8	10.6	11.8	11.4	13.1	13.1	13.9	15.6	14.7
Operating expenses	26.5	26.2	27	29.7
Operating income	6.24	4.85	1.74	-7.11	-8.87	0.24	1.97	1.98	0.07	-3.73
Interest expense	0.84	0.91	1.18	1.06	1.09	1.02	0.93	0.83	0.78	0.74
Other non-operating income	-0.34	-0.32	-0.38	-0.63	-0.62	3.21	-0.51	2.3	1.05	4.6
Pre-tax income	5.9	4.53	1.36	-7.74	-9.5	3.45	1.46	4.27	1.12	0.88
Income tax	2.62	-0.99	0.37	-2.07	-3.09	0.29	0.38	1.15	0.27	0.26
Net income	3.28	5.52	1	-5.67	-6.41	3.17	1.08	3.12	0.85	0.61
EBITDA	12.9	12	9.32	0.51	-1.89	6.51	7.91	8.13	7.16	3.15
EPS, basic	0.12	0.23	0.04	-0.24	-0.28	0.14	0.05	0.15	0.04	0.03
EPS, diluted	0.12	0.23	0.04	-0.24	-0.28	0.14	0.05	0.15	0.04	0.03
Shares, basic (weighted)	27.3	24	23.9	23.5	23.2	22.8	22.3	21.3	20.8	20.6
Shares, diluted (weighted)	27.3	24	23.9	23.5	23.2	22.8	22.3	21.3	20.8	20.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	4.8	9.79	9.38	13	29.3	32.7	25.7	22.8	21	20.6
Short-term investments	0	0	0	0	0	0	0	0	0	0
Receivables	5.06	3.98	7.29	10.1	7.91	6.57	6.85	7.69	9.37	12.1
Inventory	66.9	75.5	74.3	69.5	57.6	52.5	51.7	58.1	62.1	67
Other current assets	1.73	1.33	1.96	1.9	2.35	1.46	1.65	2.06	1.73	1.81
Total current assets	102	111	113	107	106	106	97.6	98.6	98	109
Property, plant and equipment	123	129	126	119	114	111	113	116	114	103
Lease right-of-use assets				0.41	0
Goodwill	1.26	1.26	1.26	1.26	1.26	1.26	1.26	1.26	1.26	0
Intangible assets	14.8	13.2	11.9	11	9.24	8.32	6.48	5.75	4.49	2.68
Other non-current assets	0.25	0.25	0.29	0.67	0.24	0.61	0.06	0.16	0.1	0.08
Total assets	241	254	252	238	230	227	219	222	218	215
Accounts payable	5.86	10.3	12.6	10.4	9.42	13.2	11.5	12.8	11.6	9.75
Accrued liabilities	11.8	10.3	12.6	10.4
Deferred revenue		0.59	0.38	0.41	0.27	0.37	0.39	0.67	0.39	0.47
Short-term debt	0.63	1.13	1.13	1.13	3.39	1.13	1.13	1.13	1.13	1.13
Total current liabilities	12.8	12	14.1	11.9	13.1	14.7	13	14.6	13.1	11.3
Long-term debt	14.6	23.3	22.2	21.1	21.2	18.8	17.7	16.5	15.4	14.3
Lease liabilities				0.26	0.09	0
Other non-current liabilities			0.02	0.26	0.09	0.01	0.01	0.01	0.03	0.02
Total liabilities	33.9	40.3	41.1	36.3	34.8	34.2	31.8	33.9	31.6	28.7
Total debt	15.3	24.4	23.3	22.2	24.6	19.9	18.8	17.7	16.5	15.4
Paid-in capital	278	278	278	278	278	278	278	279	278	279
Retained earnings	-70.2	-64	-66.7	-75.9	-82.3	-85.3	-91.2	-90.7	-92.3	-92
Other comprehensive income	0.01	-0.02	-0.02	0.01	0.01	0	-0.05	0.09	0.16	0
Shareholders' equity	208	213	211	202	196	193	187	188	187	187
Total equity	208	213	211	202	196	193	187	188	187	187
Total liabilities and equity	241	254	252	238	230	227	219	222	218	215
Shares outstanding	27.1	24	23.7	23.2	23.2	22.5	21.4	21	20.6	20.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	3.28	5.52	1	-5.67	-6.41	3.17	1.08	3.12	0.85	0.61
Depreciation and amortization	6.69	7.14	7.58	7.62	6.98	6.26	5.94	6.16	7.09	6.87
Stock-based compensation		0	0	0	0.03	0.17	0.36	0.5	-0.12	0.11
Deferred income tax	2.77	-1.58	0.34	-1.73	-2.61	0.27	0.38	1.15	0.27	0.26
Change in receivables	1.29	1.07	-3.3	-2.94	2.04	1.33	-0.28	-0.82	-1.54	-2.78
Change in inventory	-7.28	-8.11	-0.99	2.81	5.48	3.24	-0.6	-7.3	-4.94	-6.98
Change in payables	1.08	-0.31	1.4	-2.35	-2.25	3.13	-2.43	1.16	-1.91	-2.36
Cash from operations	10.2	6.42	8.67	3.64	13.6	18.7	7.49	5.95	2.68	1.42
Capital expenditures	-14.9	-14	-6.09	-5.36	-3.1	-4.51	-7.57	-9.05	-5.37	-3.92
Acquisitions	-7.32	0	0
Purchases of investments	-5.75	-5.75	-11.8	-10	-8.5	-12.5	-11.8	-18.9	-21.4	-11
Sales and maturities of investments	7.5	9.5	12.5	19.3	10	8.5	12.5	22.8	25.8	14.5
Cash from investing	-20.4	-10.2	-5.24	4.71	0.34	-8.19	-6.39	-5.14	-0.91	-0.36
Debt issued	0	10	0	0	3.82	0
Debt repaid	-0.64	-0.77	-1.14	-1.14	-1.43	-0.86	-1.14	-1.14	-1.14	-1.14
Share buybacks	-2.63	0	-2.52	-3.49	0	-6.24	-6.99	-2.6	-2.38	-0.35
Cash from financing	-3.27	8.78	-3.85	-4.75	2.4	-7.1	-8.13	-3.74	-3.52	-1.49
Net change in cash	-13.5	5	-0.42	3.61	16.3	3.42	-7.03	-2.93	-1.75	-0.44
Free cash flow	-4.76	-7.58	2.58	-1.71	10.5	14.2	-0.08	-3.1	-2.69	-2.5
Interest paid	0.72	0.83	1.31	1.31	1.56	0.91	1.12	1.01	0.93	0.9
Income taxes paid	0	0	0.51	0	0	0	0.01	0.01	0.01	0.03

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.42 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	45.4%	Gross profit / revenue.
Operating margin	-3.2%	Operating income / revenue.
EBITDA margin	6.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	1.5%	Pre-tax income / revenue.
Net margin	1.0%	Net income / revenue.
FCF margin	8.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.0%	Cash from operations / revenue.
Effective tax rate	34.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	0.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.3%	Net income / average total assets.
Return on invested capital (ROIC)	-0.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	45.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.0%	Capital expenditures / revenue.
D&A / revenue	9.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-12.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-5,582.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-56.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-26.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-28.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-17.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-25.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-15.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-47.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-42.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-36.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	0.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-0.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	10.5x	Current assets / current liabilities.
Quick ratio	2.09x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.03x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.20x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.6%	Total debt / total assets.
Liabilities / assets	21.2%	Total liabilities / total assets.
Net debt	$25.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.72x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-1.57x	Operating income / interest expense.
Working capital	$109.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	5.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$173.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.31x	Revenue / average total assets.
Fixed asset turnover	0.72x	Revenue / average property, plant and equipment.
Inventory turnover	0.45x	Cost of revenue / average inventory.
Days inventory	816 days	365 x average inventory / cost of revenue.
Receivables turnover	5.90x	Revenue / average receivables.
Days sales outstanding	62 days	365 x average receivables / revenue.
Days payables	91 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	787 days	Days inventory + days sales outstanding - days payables.
FCF conversion	818.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	38.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$3.52	Revenue / diluted weighted shares.
FCF per share	$0.28	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.46	Cash from operations / diluted weighted shares.
Book value per share	$9.03	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$8.41	Tangible book value / shares outstanding.
Cash per share	$0.58	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$91.0M	Share price x shares outstanding.
Enterprise value	$116.0M	Market cap + total debt - cash - short-term investments.
P/E	129x	Market cap / net income. Only when net income is positive.
P/S	1.26x	Market cap / revenue.
P/B	0.49x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.53x	Market cap / tangible book value, when positive.
P/FCF	15.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.67x	Market cap / cash from operations, when positive.
EV/Sales	1.60x	Enterprise value / revenue.
EV/EBITDA	26.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	20.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.3%	Free cash flow / market cap.
Earnings yield	0.8%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was Crimson Wine Group, Ltd's revenue in fiscal 2025?

Crimson Wine Group, Ltd reported revenue of $65.1M for fiscal 2025, 10.8% lower than the year before.

Was Crimson Wine Group, Ltd profitable in fiscal 2025?

Yes. Net income was $613.0K, a net margin of 0.9%.

How much free cash flow did Crimson Wine Group, Ltd generate in fiscal 2025?

Cash from operations of $1.4M minus capital expenditures of $3.9M left free cash flow of -$2.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Crimson Wine Group, Ltd